health
March 6, 2026
Serbia: Around 250 New Cases of Hodgkin's Lymphoma Diagnosed Annually
In Serbia, approximately 250 new cases of Hodgkin's lymphoma are diagnosed annually, and it is estimated that about 40% of patients receive a diagnosis at an advanced stage, when treatment is more complex and prolonged, making it important for patients to receive targeted biological therapy in the first line of treatment.
TL;DR
- Approximately 250 new cases of Hodgkin's lymphoma are diagnosed annually in Serbia.
- 40% of patients receive a diagnosis at an advanced stage, complicating treatment.
- Current first-line treatments in Serbia are over 50 years old and cause significant long-term side effects.
- Targeted biological therapy is highly effective in the first line, curing nearly all advanced cases according to clinical studies.
- In Serbia, targeted biological therapy is often only available after relapse, unlike in most European countries.
- Patient advocacy groups and medical professionals are calling for immediate access to modern therapies for better outcomes.
- Patient testimonials highlight severe health consequences from older, aggressive treatments, including organ damage and infertility.
- There is a significant discrepancy between treatment standards in Serbia and neighboring countries, leading to patient concern.
Continue reading the original article